CASI
CASI Pharmaceuticals, Inc. Ordinary Shares
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
CASI Stock Analysis: Buy, Sell, or Hold?
$0.21
-0.59 (-74.06%)
▼
5d:
-73.37%
30d:
-78.83%
90d:
-83.13%
Open in Live Scanner
70/30 Portfolio Builder
Last Earnings: Mar 30, 2026
Updated Feb 25, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (64%)
Quality Score
42/100
Position
FAIR
Forward P/E & Valuation
-0.2x
Next 12M consensus est.
Wall Street Target
$4.00
+1827.7% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$0.21 / $0.97
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: CASI is down 73.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When CASI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CASI is currently trading at $0.21, which is considered fair based on recent price action.
Technical Outlook: Technically, CASI is in a strong downtrend. The price is currently testing key support at $0.21. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 74.1% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.00 (+1827.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CASI is in a strong downtrend. The price is currently testing key support at $0.21. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 74.1% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.00 (+1827.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
42/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
64.2%
Trading Range & Key Levels
Support Level
$0.21
Resistance Level
$0.97
Current Trend
Strong Downtrend
Technical data as of
Feb 25, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-74.1%)
- BULLISH: Trading 1827.7% below Wall St target ($4.00)
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.15
Wall Street Target
$4.00
(+1827.7%)
Revenue Growth (YoY)
-60.5%
Profit Margin
-184.0%
Share CASI Analysis
Share this live CASI analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CASI)
Bearish
5 Retail Mentions
Reddit / WSB Comments
1
Bearish
Retail Stream Volume
4 msgs
24h retail stream
Last Tracked
Feb 26, 2026
Daily AI digest
AI Retail Discussion Summary:
CASI Pharmaceuticals announced it will be delisted from Nasdaq due to failure to meet listing requirements. The Company intends to trade on the OTC market following delisting.
Key Retail Themes:
delisting from Nasdaq
intention to trade on OTC market
Aggregated from r/wallstreetbets, r/stocks & retail trader streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 22, 2026 5:20 AM ET
Data refreshes hourly during market hours. Next update: 6:20 AM
Data refreshes hourly during market hours. Next update: 6:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CASI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$109 | 71 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 39 SELL |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 42 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
23 analysts |
$85 | 52 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CASI Research Pages
CASI Technical Chart
CASI Price Prediction
CASI Intrinsic Value DCF
CASI Earnings Date
CASI Investment Advisor
CASI Fair Price Analyzer
CASI Target Price Playground
CASI 5-Day Options Simulator
CASI LEAP Simulator
CASI Supply Chain Tear-Down
Engineering R&D & Supply-Chain Velocity Hub
AI Chip Cost & Reticle Wall Visualizer
House Thesis Scoreboard & Risk Guard
CASI Competitors
Part B: Tradestie Flagship Market Scanners